Systolic versus diastolic blood pressure versus pulse pressure
- 365 Downloads
Elevation of systolic blood pressure (BP) has been recognized as an independent risk factor that far exceeds the risk associated with an elevated diastolic BP in older patients with hypertension. Isolated systolic hypertension (ISH) is a disorder typically defined when the systolic BP is greater than 140 mm Hg but with diastolic BP below 90 mm Hg. Pulse pressure (the difference between systolic and diastolic pressure) has recently become an active area of discussion in the literature as an independent factor of cardiovascular risk. An increased pulse pressure nearly always indicates reduced vascular compliance of large arteries and, by definition, is always increased in patients with isolated systolic hypertension. Although the evidence that a widened pulse pressure is an independent marker of cardiovascular risk is quite well established, therapeutic morbidity and mortality studies in ISH have focused on reductions in systolic pressure. At the present time, outcomes data have not been well established for reductions in pulse pressure in older patients with hypertension.
KeywordsPulse Pressure Systolic Hypertension Eplerenone Fosinopril Isolate Systolic Hypertension
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The 6th report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997, 157:2413–2446.Google Scholar
- 7.Smulyan H, Safar ME: The diastolic blood pressure in systolic hypertension. Ann Intern Med 2000, 32:233–237.Google Scholar
- 14.Benetos A, Zureik M, Morcet J, et al.: A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 2000, 35:673–680. Important epidemiologic assessment of the respective importance of systolic versus diastolic BP in patient outcomes.PubMedCrossRefGoogle Scholar
- 17.Staessen JA, Thijs L, Fagard R, et al.: Predicting cardiovascular risk using conventional versus ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999, 282:539–546. First study that has demonstrated the prognostic relevance of ambulatory BP prospectively in an entirely untreated patient population.PubMedCrossRefGoogle Scholar
- 18.Verdecchia P, Schillaci G, Borgioni C, et al.: Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension 1998, 32:983–988. First analysis that showed that ambulatory pulse pressure is superior to clinic pulse pressure in predicting cardiovascular morbidity.PubMedGoogle Scholar
- 22.ALLHAT Collaborative Research Group: Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorhtalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000, 283:1967–1975. Important large, simple trial showing that doxazosin was less effective in controlling systolic BP compared with chlorthalidone, and was associated with a 19% increase in stroke rate.CrossRefGoogle Scholar
- 24.Bohmer F, Baronch R, Reinfruk J: Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg. J Cardiovasc Pharmacol 1998, 12(Suppl 4):S45-S46.Google Scholar
- 25.Stallard MP, Park GD, Stewart WH: Systolic blood pressure response in three subgroups of hypertensives treated with sustained release diltiazem. J Cardiovasc Pharmacol 1998, 12(Suppl 6):S117-S119.Google Scholar
- 28.Epstein M, Menard J, Alexander J, Roniker B: Eplerenone, a novel and selective aldosterone receptor antagonist: efficacy in patients with mild to moderate hypertension [abstract]. Circulation 1998, 98:I–98-I–99.Google Scholar